Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide (OCEAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03151811
Recruitment Status : Active, not recruiting
First Posted : May 12, 2017
Last Update Posted : September 18, 2020
Sponsor:
Information provided by (Responsible Party):
Oncopeptides AB

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 31, 2021
Estimated Study Completion Date : July 2022